SERUM SOMATOMEDIN ACTIVITY DEPRESSED AFTER GLUCAGON ADMINISTRATION IN MAN.
- 1 May 1977
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 44 (5) , 1006-1009
- https://doi.org/10.1210/jcem-44-5-1006
Abstract
The variations in serum somatomedin (SM) activity were compared in 14 subjects after glucagon injectian(l mg im), and in 10 controls. A significant decrease in SM activity was observed 30 and 60 min after glucagon (p < 0.01 to <0.00l) whereas no significant change was noted in the controls. Analysis of the dose-response curves suggests that this decrease reflects depressed SM concentration. No correlation was found between the variations of growth hormone (GH), cortisol, or fatty acids and those of SM activity. The maximum variations in glycemia, insulin and SM activity occured during the same time interval. These results suggest that glucagon may play some role in the regulation of circulating SM.This publication has 4 references indexed in Scilit:
- THE LIVER AS A SOURCE OF SOMATOMEDINActa Endocrinologica, 1976
- THE SERUM HALF-LIFE OF SOMATOMEDIN ACTIVITY: EVIDENCE FOR GROWTH HORMONE DEPENDENCEActa Endocrinologica, 1976
- The Effects of Insulin and Growth Hormone on the Release of Somatomedin by the Isolated Rat LiverEndocrinology, 1976
- STUDIES ON SULFATION FACTOR (SF) ACTIVITY OF HUMAN SERUMActa Endocrinologica, 1961